Crinetics Pharmaceuticals

General Information
Business:

 

We are a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Endocrine pathways function to maintain homeostasis and commonly use peptide hormones acting through G protein coupled receptors, or GPCRs, to regulate many aspects of physiology including growth, energy, metabolism, gastrointestinal function and stress responses. 

 

Industry: PHARMACEUTICAL PREPARATIONS
Employees: 34
Founded: 2008
Contact Information
Address 10222 Barnes Canyon Road, Bldg. #2, San Diego, California 92121, US
Phone Number (858) 450-6464
Web Address http://www.crinetics.com
View Prospectus: Crinetics Pharmaceuticals
Financial Information
Market Cap $352mil
Revenues $2.4 mil (last 12 months)
Net Income $-12.0 mil (last 12 months)
IPO Profile
Symbol CRNX
Exchange NASDAQ
Shares (millions): 6.0
Price range $17.00 - $17.00
Est. $ Volume $102.0 mil
Manager / Joint Managers J.P. Morgan/ Leerink Partners/ Piper Jaffray
CO-Managers -
Expected To Trade: 7/18/2018
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change